Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis
A 9 Month,3-arm Multicenter Clinical Trial of Treatment With Periocline Gel (2.1% Minocycline HCl) for Adjunctive Use to Scaling and Root Planing (SRP) in Adults With Periodontal Disease.
1 other identifier
interventional
602
1 country
10
Brief Summary
Periodontal disease (commonly called gum disease) is generally treated by deep cleaning of the root surfaces of the teeth. This is also called scaling and root planing. Placing a topical antibiotic into the periodontal pocket at the time of scaling and root planing may help reduce pocket depth and thus help the periodontal disease. Periocline (minocycline HCl) 2.1% gel is a topical antibiotic approved in a number of countries for this use, and is now being tested in the US.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jan 2006
Typical duration for phase_3
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 11, 2007
CompletedFirst Posted
Study publicly available on registry
September 14, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedResults Posted
Study results publicly available
May 9, 2014
CompletedMay 9, 2014
April 1, 2014
2.9 years
September 11, 2007
July 10, 2013
April 10, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pocket Depth.
Average change of Pocket Depth at 9 months from baseline
baseline & 9 months
Study Arms (3)
Scaling and root planing + SHAM TX
SHAM COMPARATORsham treatment
Scaling and root planing + Vehicle
PLACEBO COMPARATORPlacebo
Scaling & root planing + Periocline Gel
ACTIVE COMPARATORMinocycline HCL 2.1%
Interventions
Minocycline HCl 2.1% gel as an adjunct to scaling and root planing. Dosing is by topical delivery into gingival pockets at baseline, 2 weeks, 4 weeks, 3 months and 6 months.
scaling and root planing
Eligibility Criteria
You may qualify if:
- moderate to severe periodontitis
You may not qualify if:
- recent periodontal therapy
- certain medical or dental conditions
- pregnancy
- allergy to active drug or related drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunstar Americaslead
Study Sites (10)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
University of California - San Francisco
San Francisco, California, 94143, United States
University of Florida
Gainsville, Florida, 32610, United States
University of Maryland - Dental School
Baltimore, Maryland, 21201, United States
Boston University Dental School
Boston, Massachusetts, 02118, United States
University of Michigan Oral Health Research Center
Ann Arbor, Michigan, 48106, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
State University of New York at Buffalo, Dental Medicine
Buffalo, New York, 14214, United States
University of Pennsylvania Dental School
Philadelphia, Pennsylvania, 19104, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Marie Wilson, Clinical Program Manager
- Organization
- Sunstar Americas, Inc
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Genco, DDS, PhD
State University of New York at Buffalo
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2007
First Posted
September 14, 2007
Study Start
January 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
May 9, 2014
Results First Posted
May 9, 2014
Record last verified: 2014-04